The investigators have recently received notification of an SAE (Serious adverse event) at another site that has already begun recruitment for this study. The MediWatch report for that SAE is included as a Supporting document on WEBRIDGE. Additionally, a protocol change clarifying the procedures to collect lab information to calculate the estimate Creatinin CVlearance (CLer) has been submitted. This document has been added as a supporting document on WEBRIDGE.